BIASUTTO, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2923
EU - Europa 338
AS - Asia 212
Totale 3473
Nazione #
US - Stati Uniti d'America 2917
CN - Cina 149
IT - Italia 133
SE - Svezia 58
VN - Vietnam 51
FI - Finlandia 43
GB - Regno Unito 37
DE - Germania 20
UA - Ucraina 19
IN - India 9
IE - Irlanda 7
RO - Romania 6
CA - Canada 5
DK - Danimarca 4
SI - Slovenia 3
BE - Belgio 2
IR - Iran 2
PT - Portogallo 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
FR - Francia 1
MX - Messico 1
SG - Singapore 1
Totale 3473
Città #
Fairfield 500
Woodbridge 358
Chandler 346
Ann Arbor 294
Houston 242
Ashburn 191
Seattle 183
Cambridge 182
Wilmington 170
Jacksonville 66
Beijing 60
San Diego 56
Padova 53
Princeton 52
Dong Ket 51
Boardman 35
Medford 32
Des Moines 28
Roxbury 27
Nanjing 22
Helsinki 16
Verona 15
Hebei 12
Jinan 8
Nanchang 8
Shenyang 7
Dublin 5
Jiaxing 5
Chicago 4
Kharkiv 4
Bologna 3
Changsha 3
Hefei 3
Ljubljana 3
Milan 3
Ningbo 3
Redwood City 3
Taiyuan 3
Brescia 2
Brussels 2
Guangzhou 2
Indiana 2
Kunming 2
Lanzhou 2
New York 2
Norwalk 2
Patti 2
Peschiera 2
Rieti 2
Sandrigo 2
Tianjin 2
Treviso 2
Berkeley 1
Bibbiano 1
Busto Arsizio 1
Chatsworth 1
Cleveland 1
Edmonton 1
Fiano Romano 1
Fontanelle 1
Fuzhou 1
Gandhi Nagar 1
Gorla Maggiore 1
Hangzhou 1
Illasi 1
Kashan 1
Lendinara 1
Lisbon 1
London 1
Madrid 1
Media 1
Mesagne 1
Modena 1
Monterrey 1
Nürnberg 1
Orsogna 1
Palermo 1
Potenza Picena 1
Redmond 1
Reghin 1
Rockville 1
Rome 1
San Giovanni Lupatoto 1
Saponara 1
Schenectady 1
Taizhou 1
Tappahannock 1
Toronto 1
Vancouver 1
Veggiano 1
Venezia 1
Zhengzhou 1
Totale 3124
Nome #
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 171
A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols 130
Development of mitochondria-targeted derivatives of resveratrol 130
Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma 119
Determination of Quercetin and Resveratrol in Whole Blood-Implications for Bioavailability Studies 117
Synthesis of resveratrol sulfates: turning a nightmare into a dream 113
Impact of intracellular ion channels on cancer development and progression 112
Impact of mitochondriotropic quercetin derivatives on mitochondria 110
Heterogeneity and standardization of Phase II metabolism in cultured cells 107
Redox Properties and Cytotoxicity of Synthetic Isomeric Mitochondriotropic Derivatives of the Natural Polyphenol Quercetin 102
Pharmacological modulation of mitochondrial ion channels. 101
Cytotoxicity of mitochondria-targeted resveratrol derivatives: interactions with respiratory chain complexes and ATP synthase. 101
Synthesis and Testing of Novel Isomeric Mitochondriotropic Derivatives of Resveratrol and Quercetin 99
Novel lipid-mimetic prodrugs delivering active compounds to adipose tissue 98
New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile 96
Ester-based precursors to increase the bioavailability of quercetin 94
Acetal Derivatives as Prodrugs of Resveratrol. 94
Cytotoxicity of a mitochondriotropic quercetin derivative: Mechanisms 93
Resveratrol derivatives as a pharmacological tool 92
Resveratrol and health: the starting point. 89
Amino acid carbamates as prodrugs of resveratrol 87
Pharmacokinetics and tissue distribution of pterostilbene in the rat 86
Quercetin Mitochondriotropic Derivatives Antagonize Nitrate Tolerance and Endothelial Dysfunction of Isolated Rat Aorta Rings 84
Derivati dello psoralene come agenti anti-tumorali selettivi 80
New Water-Soluble Carbamate Ester Derivatives of Resveratrol 79
Potential anti-cancer activity of 7-O-pentyl quercetin: Efficient, membrane-targeted kinase inhibition and pro-oxidant effect 79
Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted reat intestinal segments 78
Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds 77
Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants. 72
Improving the efficacy of plant polyphenols. 71
Soluble polyphenols: synthesis and bioavailability of 3,4',5-tri(alpha-D-glucose-3-O-succinyl)resveratrol 70
Quercetin can act either as an inhibitor or an inducer of the Mitochondrial Permeability Transition Pore: a demonstration of the ambivalent redox character of polyphenols 65
Pterostilbene improves cognitive performance in aged rats: An in vivo study 63
Novel mitochondria-targeted furocoumarin derivatives as possible anti-cancer agents 60
Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3 52
Nanocostrutti comprendenti nanoparticelle lipidiche solide rivestite da un guscio idrofilo 45
Come sfruttare il potenziale farmacologico dei polifenoli vegetali: modificazioni reversibili per aumentarne la biodisponibilità/bioefficacia 45
Browning Effects of a Chronic Pterostilbene Supplementation in Mice Fed a High-Fat Diet 42
Nuovi derivati del resveratrolo 33
An angiopep2-paptp construct overcomes the blood-brain barrier. New perspectives against brain tumors 23
Corrigendum to “Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family” [Redox Biol. 37 (2020 Sep 6) 101705–101721](S2213231720309101)(10.1016/j.redox.2020.101705) 18
Targeting mitochondrial ion channels for cancer therapy 17
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo 11
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges 9
C17 corrector for the treatment of sarcoglycanopathy: preliminary ADME studies 6
Totale 3520
Categoria #
all - tutte 6704
article - articoli 6091
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 253
selected - selezionate 0
volume - volumi 168
Totale 13216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201851 0000 00 00 145293
2018/2019365 711813 31 122 359129108
2019/2020813 86251647 10078 7795 112925233
2020/2021629 23401450 8237 1650 65848286
2021/2022666 18886834 5044 3864 362561140
2022/2023550 9582798 8794 636 45000
Totale 3520